This summary was created by AI, based on 4 opinions in the last 12 months.
Smith & Nephew PLC, operating under the symbol SNN-N, specializes in equipment for hip and knee replacements, an area expected to see continued demand due to demographic trends and growth in related activities. Analysts note that while the company has faced earnings challenges in recent years, it shows signs of recovery with revenues re-accelerating. Comparatively, it trades at attractive valuations, notably at a lower price-to-earnings ratio than its competitor, SYK, making it an appealing option for investors. Activist interest suggests there could be significant underlying value, potentially unlocking further growth as the markets adjust. With a current yield reflecting more favorable financial performance, the outlook appears cautiously optimistic.
Global leader in hip and knee replacement, also wound management. Great secular growth story. Earnings weak last couple of years. Demographic and pickleball play. Lowest valuation in 50 years, 14x PE, 12x next year's PE. Revenues re-accelerating. Earnings and margins growing. Yield is 3.7%.
Cheaper than SYK, and probably more narrowly focused.
Smith & Nephew PLC is a American stock, trading under the symbol SNN-N on the New York Stock Exchange (SNN). It is usually referred to as NYSE:SNN or SNN-N
In the last year, 1 stock analyst published opinions about SNN-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Smith & Nephew PLC.
Smith & Nephew PLC was recommended as a Top Pick by on . Read the latest stock experts ratings for Smith & Nephew PLC.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Smith & Nephew PLC In the last year. It is a trending stock that is worth watching.
On 2025-04-18, Smith & Nephew PLC (SNN-N) stock closed at a price of $25.935.
Demand continues to grow quite nicely. Competes with SYK (a slightly better business, though at 29x PE), and grows at similar rates. Trades at 13x PE for 10% EPS growth. Likes the risk/reward. Yield is 2.2%.
(Analysts’ price target is $29.21)